Patents Represented by Attorney, Agent or Law Firm Steve T. Zelson, Esq.
  • Patent number: 6087148
    Abstract: A method for purification, and isolation in crystalline form, of a cellulase from a broth comprises: treating the broth with a crystallization-effective amount of a water-miscible organic solvent (e.g. a lower aliphatic alcohol or ketone); and isolating the cellulase in question in crystalline form.
    Type: Grant
    Filed: August 28, 1998
    Date of Patent: July 11, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Anders Rancke-Madsen, Mads Aage Laustsen
  • Patent number: 6083957
    Abstract: The present invention relates to therapeutically active quaternary azacyclic or azabicyclic compounds with formula I: ##STR1## wherein X is oxygen or sulfur and wherein G is selected from the group of azacyclic or azabicyclic ring systems consisting of: ##STR2## a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in treating a cholinergic deficit in the peripheral system.
    Type: Grant
    Filed: April 17, 1997
    Date of Patent: July 4, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Preben H. Olesen, Per Sauerberg
  • Patent number: 6083960
    Abstract: The present invention relates to a compound of general formula I ##STR1## for treating medical disorders related to binding to human somatostatin receptor subtypes.
    Type: Grant
    Filed: September 16, 1999
    Date of Patent: July 4, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Michael Ankersen, Florenzio Zaragoza Dorwald, Carsten Enggaard Stidsen, Albert Michael Crider
  • Patent number: 6074372
    Abstract: A dose setting mechanism for a drug administration device and an injection syringe having such a dose setting mechanism are provided. The injection syringe has a housing accommodating an ampoule (3) containing medicine sufficient for a number of dosed injections, an injection press button (7), a piston rod (13) for co-operation with a piston in the ampoule (3) when injecting, and a dose setting mechanism comprising a rotatable dose setting element (5) interconnected with the press button. The dose setting mechanism further comprises a dose administration wheel (11) connected with the piston rod (13) and a coupling ring (12) connected with the dose setting element (5) and the press button (7).
    Type: Grant
    Filed: June 3, 1998
    Date of Patent: June 13, 2000
    Assignee: Novo Nordisk A/S
    Inventor: Steffen Hansen
  • Patent number: 6074863
    Abstract: A lipase variant of a parent lipase comprising a trypsin-like catalytic triad including an active serine located in a predominantly hydrophobic, elongated binding pocket of the lipase molecule and, located in a critical position of a lipid contact zone of the lipase structure, an amino acid residue different from an aromatic amino acid residue, which amino acid residue interacts with a lipid substrate at or during hydrolysis, in which lipase variant said amino acid residue has been replaced by an aromatic amino acid residue so as to confer to the variant an increased specific activity as compared to that of the parent lipase. The parent lipase may be a C. antarctica lipase A essentially free from other substances from C. antarctica, which comprises the amino acid sequence shown in SEQ ID No. 2, or a variant of said lipase which (1) has lipase activity, (2) reacts with an antibody reactive with at least one epitope of C. antarctica lipase A having th eamino acid sequence SEQ ID No.
    Type: Grant
    Filed: December 22, 1994
    Date of Patent: June 13, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Allan Svendsen, Shamkant Anant Pathar, Michi Egel-Mitani, Kim Borch, Ib Groth Clausen, Mogens Trier Hansen
  • Patent number: 6071735
    Abstract: The present invention relates to an isolated enzyme exhibiting cellulolytic (endoglucanase) activity at alkaline pH, an enzyme composition comprising the enzyme, a DNA construct encoding the enzyme, methods for producing the enzyme or enzyme composition, a detergent composition comprising the enzyme, and methods for using the enzyme in, e.g., providing localized variation in the color density of dyed fabric, improving the drainage of an aqueous suspension of paper pulp, and de-inking of recycled paper.
    Type: Grant
    Filed: October 22, 1997
    Date of Patent: June 6, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Martin Schulein, Karen Margrethe Oxenb.o slashed.ll, Lene Nonboe Andersen, S.o slashed.ren Flensted Lassen, Markus Sakari Kauppinen, Jack Bech Nielsen
  • Patent number: 6069000
    Abstract: The present invention relates to an enzyme with pectin esterase activity, a DNA construct encoding the enzyme with pectin esterase activity, a method of producing the enzyme, an enzyme composition comprising said enzyme with pectin esterase activity, and the use of said enzyme and enzyme composition for a number of industrial applications.
    Type: Grant
    Filed: August 19, 1998
    Date of Patent: May 30, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Lene Nonboe Andersen, Markus Kauppinen, Gitte Budolfsen
  • Patent number: 6066486
    Abstract: A cholesterol esterase from Pseudomonas fragi FERM BP-1051 can be used to hydrolyze cholesterol ester. The enzyme can be used in cleaning compositions.
    Type: Grant
    Filed: September 27, 1995
    Date of Patent: May 23, 2000
    Assignee: Novo Nordisk A/S
    Inventor: Martin Barfoed
  • Patent number: 6066481
    Abstract: The present invention relates to a method for crystallization of a protein obtained from a protein-containing solution which involves (a) treating the protein-containing solution with a salt containing a sulphur atom having an oxidation state less than 6, and (b) recovering the protein in crystalline form.
    Type: Grant
    Filed: August 27, 1998
    Date of Patent: May 23, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Stig Nielsson, Mads Aage Laustsen
  • Patent number: 6060298
    Abstract: The present invention relates to an isolated polypeptide exhibiting phytase activity, the corresponding cloned DNA sequences, a process for preparing the polypeptide, and the use thereof for a number of industrial applications, in particular in animal feed. The novel phytase is derived from Peniophora lycii and has some interesting features, such as high initial affinity for the 6-position of phytic acid, a high intial rate of liberating phosphate from phytic acid and an exceptionally high specific activity.
    Type: Grant
    Filed: December 12, 1997
    Date of Patent: May 9, 2000
    Assignee: Novo Nordisk A/S
    Inventors: S.o slashed.ren Flensted Lassen, Lisbeth Bech, Claus Crone Fuglsang, Anders Ohmann, Jens Breinholt, Peter Rahbet stergaard
  • Patent number: 6060274
    Abstract: The present invention relates to Bacillus hosts transformed with a vector comprising a DNA sequence encoding for a cellulose binding domain (CBD) and capable of expressing said sequence, the expressed polypeptide protein consisting essentially of one or more non-catalytic domains; the cellulose binding domain having a molecular weight in the range of from 4 kD to 35 kD and being obtainable from a microorganism or from a plant, preferably from a bacterium or a fungus; the Bacillus host e.g. being one of the species Bacillus subtilis, Bacillus licheniformis, Bacillus megaterium, Bacillus stearothermophilos, and Bacillus amyloliquefaciens; and a Bacillus expression vector carrying an inserted DNA sequence encoding for a cellulose binding domain; and a method for producing a cellulose binding domain polypeptide in a Bacillus host cell.
    Type: Grant
    Filed: October 28, 1997
    Date of Patent: May 9, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Mads Eskelund Bjornvad, Martin Schulein, Per Lina Jorgensen
  • Patent number: 6060299
    Abstract: Novel mannanases may be derived from eg Bacillus subtilis strain 168 or may be encoded by polynucleotide molecules comprising a nucleotide sequence as shown in SEQ ID NO: 1. The mannanases are alkaline and are useful e.g. in cleaning compositions, for modifying plant material, and for treatment of cellulosic fibres.
    Type: Grant
    Filed: June 10, 1998
    Date of Patent: May 9, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Kotikanyadanam Sreekrishna, Kevin Johnstone, Charles Saunders, Jean-Luc Bettiol
  • Patent number: 6060442
    Abstract: The present invention relates to laccase mutants with increased oxidation potential and/or changed pH optimum and/or altered mediator pathway and/or altered O.sub.2 /OH.sup.- pathway.
    Type: Grant
    Filed: February 24, 1998
    Date of Patent: May 9, 2000
    Assignee: Novo Nordisk A/S
    Inventor: Allan Svendsen
  • Patent number: 6060091
    Abstract: A method of making an animal fodder stabilized against microbial degradation, by jet-cooking potato pulp at a temperature of between about 125.degree. C. and 140.degree. C. for between about 20 to 100 seconds, cooling the jet-cooked potato pulp, and adding a cell-wall degrading enzyme to the cooled potato pulp in order to enzymatically degrade the cell walls in the potato pulp, wherein a fodder stabilized against microbial degradation is produced.
    Type: Grant
    Filed: July 8, 1994
    Date of Patent: May 9, 2000
    Assignee: Novo Nordisk A/S
    Inventor: Hans Sejr Olsen
  • Patent number: 6051414
    Abstract: This invention is in the field of Bio-Polishing. More specifically, the invention relates to a process for achieving Bio-Polishing effects during the manufacture of cellulosic fabrics.
    Type: Grant
    Filed: March 29, 1995
    Date of Patent: April 18, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Thomas Videb.ae butted.k, Lars Dalg.ang.rd Andersen
  • Patent number: 6051689
    Abstract: The present invention relates to a recombinant glucagonlike peptide-1 (GLP-1) receptor having the nucleotide sequence of SEQ ID NO:1 or SEQ ID NO:3, wherein the receptor polypeptide binds GLP-1 with a Kd of less than 100 nM.
    Type: Grant
    Filed: September 22, 1997
    Date of Patent: April 18, 2000
    Assignee: Novo Nordisk A/S
    Inventor: Bernard Thorens
  • Patent number: 6048367
    Abstract: The present invention provides a process for removal of excess dye from newly manufactured printed or dyed fabric or yarn, comprising treatment with a rinse liquor comprising at least one enzyme selected from the group consisting of enzymes exhibiting peroxidase activity or laccase activity, an oxidation agent, and at least one mediator selected from the group consisting of aliphatic, cyclo-aliphatic, heterocyclic or aromatic compounds containing the moiety >N--OH, in particular 1-hydroxybenzotriazole.
    Type: Grant
    Filed: December 23, 1998
    Date of Patent: April 11, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Ture Damhus, Uwe Vogt
  • Patent number: 6045865
    Abstract: The present invention relates to an enzymatic process for treating a solid wood or laminated solid wood article in a liquid medium containing an oxidase enzyme, an impregnating substance and an oxidizing agent so as to fixate the impregnating substance in the wood, thereby enhancing the effect of the impregnating substance.
    Type: Grant
    Filed: March 16, 1999
    Date of Patent: April 4, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Claus Felby, Tomas Tage Hansen
  • Patent number: 6045537
    Abstract: A syringe for injection of doses of a medicine from an exchangeable cartridge has a housing comprising a cartridge holder and a dosing mechanism by which a dose is set and injected by successively advancing a piston rod to press a piston into the cartridge. The dosing mechanism comprises a threaded spindle and a nut member cooperating with the spindle. A dose is set by relative rotation of the spindle and nut member whereby the nut member is moved along the spindle. The position of the nut member on the spindle defines how far the piston rod is advanced. The spindle and the nut are locked against relative rotation when the dosing mechanism is not operated to set a dose. Access to the cartridge holder is obtained by opening a lid connected to the housing and coupled to the dosing mechanism in such a way that the locking of the nut element in its position on the spindle is released when the lid is opened, and the opening movement of the lid is transmitted to a piston rod retraction mechanism.
    Type: Grant
    Filed: December 2, 1997
    Date of Patent: April 4, 2000
    Assignee: Novo Nordisk A/C
    Inventor: Lars Peter Klitmose
  • Patent number: 6043247
    Abstract: The present invention relates to novel substituted acrylic acids, to methods for their preparation, compositions containing them, and their use for treatment of human and animal disorders, to their use for purification of proteins or glycoproteins, and to their use in diagnosis. The invention also relates to modulation of the activity of molecules with phospho-tyrosine recognition units, including protein tyrosine phosphatases (PTPases) and proteins with Src-homology-2 domains, in in vitro systems, microorganisms, eukaryotic cells, whole animals and human beings.
    Type: Grant
    Filed: April 16, 1997
    Date of Patent: March 28, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Henrik Sune Andersen, Niels Peter Hundahl M.o slashed.ller, Peter Madsen